These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 474571)

  • 21. Hematological and clinical features of sickle cell diseases: a review.
    Harkness DR
    Hemoglobin; 1980; 4(3-4):313-34. PubMed ID: 6158496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on sickle cell heterozygotes in Saudi Arabia--interaction with alpha-thalassaemia.
    el-Hazmi MA
    Acta Haematol; 1986; 75(2):100-4. PubMed ID: 3090815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and molecular characterization of Hb Hofu in eastern India.
    Purohit P; Mashon RS; Patel S; Dehury S; Pattanayak C; Das K; Nair S; Italia K; Bag S; Colah R; Patel DK
    Int J Lab Hematol; 2014 Feb; 36(1):71-6. PubMed ID: 23889802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Globin biosynthesis in sickle cell, Hb SC, and Hb C diseases.
    Kim HC; Weierbach RG; Friedman S; Schwartz E
    J Pediatr; 1977 Jul; 91(1):13-20. PubMed ID: 874650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in globin chain synthesis in hereditary persistence of fetal haemoglobin.
    Friedman S; Schwartz E; Ahern E; Ahern V
    Br J Haematol; 1976 Mar; 32(3):357-64. PubMed ID: 1252370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, hematologic and biosynthetic studies in sickle cell-betao-thalassemia: a comparison with sickle cell anemia.
    Steinberg MH; Dreiling BJ
    Am J Hematol; 1976; 1(1):35-44. PubMed ID: 984035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of sickle cell anemia with heterozygous and homozygous alpha-thalassemia-2: in vitro HB chain synthesis.
    Felice AE; Webber B; Miller A; Mayson SM; Harris HF; Henson JB; Gravely ME; Huisman TH
    Am J Hematol; 1979; 6(2):91-106. PubMed ID: 474574
    [No Abstract]   [Full Text] [Related]  

  • 28. Alpha globin gene number: population and restriction endonuclease studies.
    Brittenham G; Lozoff B; Harris JW; Kan YW; Dozy AM; Nayudu NV
    Blood; 1980 Apr; 55(4):706-8. PubMed ID: 6244018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease.
    Akinbami AO; Campbell AD; Han ZJ; Luo HY; Chui DH; Steinberg MH
    Hemoglobin; 2016; 40(1):64-5. PubMed ID: 26372199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygotes for the hereditary persistence of fetal hemoglobin: the ratio of G gamma to A gamma chains and biosynthetic studies.
    Ringelhann B; Acquaye CT; Oldham JH; Konotey-Ahulu FI; Yawson G; Sukumaran PK; Schroeder WA; Huisman TH
    Biochem Genet; 1977 Dec; 15(11-12):1083-96. PubMed ID: 603615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of HbS in sickle cell heterozygotes among some tribes in Maharashtra.
    Rao VR; Bhatia HM
    Indian J Med Res; 1988 Mar; 87():257-61. PubMed ID: 3397160
    [No Abstract]   [Full Text] [Related]  

  • 32. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.
    Labie D; Pagnier J; Lapoumeroulie C; Rouabhi F; Dunda-Belkhodja O; Chardin P; Beldjord C; Wajcman H; Fabry ME; Nagel RL
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2111-4. PubMed ID: 2580306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of heterocellular hereditary persistence of foetal haemoglobin with beta thalassaemia and sickle cell anaemia.
    Wood WG; Weatherall DJ; Clegg JB
    Nature; 1976 Nov; 264(5583):247-9. PubMed ID: 1004547
    [No Abstract]   [Full Text] [Related]  

  • 34. Raised Hb F levels in sickle cell disease are caused by a determinant linked to the beta globin gene cluster.
    Kulozik AE; Thein SL; Kar BC; Wainscoat JS; Serjeant GR; Weatherall DJ
    Prog Clin Biol Res; 1987; 251():427-39. PubMed ID: 2448811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What determines severity in sickle-cell disease?
    Schechter AN; Bunn HF
    N Engl J Med; 1982 Feb; 306(5):295-7. PubMed ID: 6172711
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical and molecular characterization of β(S) and (G)γ((A)γδβ)⁰-thalassemia in eastern India.
    Patel DK; Patel M; Mashon RS; Patel S; Dash PM; Das BS
    Hemoglobin; 2010; 34(6):604-9. PubMed ID: 21077771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, hematological and genetic features of sickle-cell anemia and sickle cell-beta thalassemia in a Brazilian population.
    Zago MA; Costa FF; Freitas TC; Bottura C
    Clin Genet; 1980 Jul; 18(1):58-64. PubMed ID: 7418254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.
    Ashley-Koch A; Yang Q; Olney RS
    Am J Epidemiol; 2000 May; 151(9):839-45. PubMed ID: 10791557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Beta globin haplotypes in hemoglobin S carriers in Colombia].
    Durán CL; Morales OL; Echeverri SJ; Isaza M
    Biomedica; 2012; 32(1):103-11. PubMed ID: 23235792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sickle cell anemia and fetal hemoglobin.
    Steinberg MH
    Am J Med Sci; 1994 Nov; 308(5):259-65. PubMed ID: 7526687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.